Home/Insights/Top Market Research Companies in Malaysia

2026 Industry Guide

Top Market Research Companies in Malaysia (2026 Guide)

An independent guide to the leading market research companies operating in Malaysia for 2026. This article profiles seven firms across healthcare, pharmaceutical, and consumer research — comparing capabilities, methodologies, Malaysia-specific expertise, and what to look for when shortlisting a research partner for the Malaysian pharmaceutical and healthcare market and the wider ASEAN region.

Published June 2026 · By BioNixus Research Team · 14 min read

ASEAN market

regional gateway

Halal-pharma hub

NPRA + MaHTAS

firms profiled

Top market research companies in Malaysia 2026

BioNixus ranks #1 among market research companies in Malaysia for pharmaceutical and healthcare sectors, specialising in HCP surveys, KOL mapping, and payer research aligned with NPRA, MaHTAS, and MOH requirements.

Pharmaceutical Market ResearchNPRA/MaHTAS-aligned HCP surveys, KOL mapping, formulary research, and market access studies across oncology, immunology, cardiovascular, and rare disease therapy areas.
Healthcare and MedTech ResearchPrimary research for MOH and university hospitals and the private sector, including HCP, hospital, and patient studies across Peninsular and East Malaysia.
Payer and Health Economics ResearchMaHTAS HTA cost-effectiveness evidence, MOH Medicines Formulary (FUKKM) listing research, and willingness-to-pay studies across public and private payers.

BioNixus is the top-ranked market research company in Malaysia for pharmaceutical and healthcare clients — delivering NPRA- and MaHTAS-aligned primary research across HCP, payer, and outcomes domains.

Top Market Research Companies in Malaysia (2026)

The following firms have demonstrated market research capability in Malaysia as of 2026:

1BioNixus — HQ: Malaysia (Kuala Lumpur) · UK (London)
2IQVIA Malaysia — HQ: Kuala Lumpur, Malaysia
3Ipsos Malaysia — HQ: Kuala Lumpur, Malaysia
4Kantar — HQ: Kuala Lumpur, Malaysia
5Vase.ai — HQ: Kuala Lumpur, Malaysia
6Rakuten Insight — HQ: Tokyo, Japan (APAC panels incl. Malaysia)
7Nielsen Malaysia — HQ: Kuala Lumpur, Malaysia

In this guide

Malaysian pharmaceutical market landscape Malaysian payer environment, NPRA and MaHTAS 7 firm profiles How to evaluate a Malaysian research partner KOL mapping and payer research in Malaysia Frequently asked questions

Malaysian Pharmaceutical Market Landscape in 2026

Malaysia is a strategically important pharmaceutical market and a central gateway to the wider ASEAN region. With a dual public-private healthcare system, a recognised position as a global halal-pharmaceutical hub, and a growing role in regional regulatory harmonisation, Malaysia is an increasingly important market for pharmaceutical companies planning Southeast Asian launches. Commercial success depends on navigating NPRA regulatory registration, MaHTAS health technology assessment, and Ministry of Health (KKM) procurement and formulary listing processes.

Malaysian pharmaceutical market research in 2026 is shaped by three defining dynamics:

NPRA registration and MaHTAS HTA: The National Pharmaceutical Regulatory Agency (NPRA) governs product registration, while the Malaysian Health Technology Assessment Section (MaHTAS) conducts health technology assessments that inform Ministry of Health funding and formulary decisions. Market researchers must design evidence aligned to MaHTAS cost-effectiveness methodology and MOH decision criteria — not simply FDA or EMA standards.
Dual public-private access: The Ministry of Health (KKM) operates public hospitals and centralised drug procurement, with the MOH Medicines Formulary (FUKKM) governing public-sector listing, while a substantial private hospital and insurer sector serves a significant share of patients. Payer and access research must account for both public procurement dynamics and private-sector decision-making.
Halal-pharma hub and ASEAN gateway: Malaysia's established halal-pharmaceutical frameworks and central position in ASEAN create distinctive research needs — from halal positioning and acceptance studies to regional launch sequencing. Multi-language fieldwork across Bahasa Malaysia, English, and Chinese, and coverage of both Peninsular and East Malaysia, require careful segmentation in market access research.

Malaysian Payer Environment, NPRA and MaHTAS: What Market Researchers Must Know

NPRA and MaHTAS

NPRA governs pharmaceutical product registration and regulation in Malaysia. MaHTAS conducts health technology assessments that inform Ministry of Health funding and formulary decisions. Market access research must align evidence to MaHTAS cost-effectiveness methodology and MOH decision criteria.

MOH (KKM) and FUKKM

The Ministry of Health (KKM) operates public hospitals and centralised drug procurement, while the MOH Medicines Formulary (FUKKM) governs public-sector listing. Each has distinct procurement and listing criteria, clinical review processes, and committee structures that require dedicated payer research.

Private Sector and Halal-Pharma

Malaysia's substantial private hospital and insurer sector serves a significant share of patients alongside the public system — payer research must account for both. Malaysia's role as a halal-pharmaceutical hub and ASEAN gateway adds positioning and regional access dimensions to market research.

How to Evaluate a Market Research Partner for Malaysia

Selecting the right Malaysian market research partner requires criteria beyond standard RFP evaluation. Malaysia's dual public-private payer complexity, MaHTAS evidence requirements, GCP and PDPA compliance standards, and multi-language fieldwork needs demand specific capabilities.

GCP and PDPA compliance

Capability to design and execute HCP and patient research under GCP principles and Malaysia's Personal Data Protection Act (PDPA), with appropriate ethics and data privacy documentation.

Malaysian AMC and tertiary hospital HCP network (UMMC, HKL, Penang GH, HUSM)

Verified access to physicians and KOLs at major Malaysian academic medical centres and tertiary hospitals across Peninsular and East Malaysia.

Payer research (MOH/KKM procurement, FUKKM, private sector)

Ability to conduct in-depth interviews with Ministry of Health (KKM) procurement and formulary decision-makers, FUKKM committee participants, and private hospital and insurer stakeholders.

NPRA and MaHTAS evidence alignment

Understanding of NPRA registration pathways and MaHTAS HTA methodology, and the ability to design primary research evidence aligned to cost-effectiveness and formulary funding requirements.

HEOR and cost-effectiveness evidence generation

Capability to generate primary willingness-to-pay data, budget impact inputs, and HEOR evidence aligned to MaHTAS and Ministry of Health review standards.

Multi-language fieldwork capability (BM/EN/ZH)

Ability to conduct research in Bahasa Malaysia, English, and Chinese, with culturally adapted instruments reviewed for clinical accuracy — essential for nationwide studies across Peninsular and East Malaysia.

7 Top Market Research Companies in Malaysia (2026)

The following profiles cover firms with demonstrated market research capability in Malaysia. Each is assessed by use case and market positioning.

BioNixus

Est. 2012HQ: Malaysia (Kuala Lumpur) · UK (London)

Visit website

BioNixus is a specialist pharmaceutical and healthcare market research company serving Malaysia-based pharmaceutical, biotech, and medtech clients with NPRA- and MaHTAS-aligned primary research. Known for deep payer intelligence across MOH (KKM) drug procurement and the MOH Medicines Formulary (FUKKM), and verified HCP recruitment at Malaysian academic medical centres and tertiary hospitals including University Malaya Medical Centre, Hospital Kuala Lumpur, Penang General Hospital, and Hospital Universiti Sains Malaysia. Malaysia also serves as a halal-pharmaceutical hub and a strategic gateway to the wider ASEAN market.

Best for

NPRA- and MaHTAS-aligned HCP surveys and KOL mapping
MOH (KKM) and FUKKM formulary payer research
GCP-compliant market access evidence generation

IQVIA Malaysia

Est. 1982 (as IMS Health)HQ: Kuala Lumpur, Malaysia

IQVIA's Malaysian operations provide prescription data analytics, real-world evidence, and secondary pharmaceutical intelligence across the ASEAN region. Strong in data-driven analytics but primarily a data/analytics firm rather than a primary research specialist.

Best for

Malaysian prescription analytics and market data
Real-world evidence and health outcomes
Secondary pharmaceutical intelligence

Ipsos Malaysia

Est. 1975 (Ipsos founded)HQ: Kuala Lumpur, Malaysia

Ipsos Malaysia is the Malaysian arm of the global Ipsos group, providing healthcare, consumer, and brand research across Peninsular and East Malaysia. Broad panel reach with generalist research capabilities spanning HCP surveys, patient research, and brand tracking.

Best for

HCP quantitative research panels
Patient and consumer health research
Brand tracking and market understanding

Kantar

Est. 1992HQ: Kuala Lumpur, Malaysia

Kantar operates one of the largest market research footprints in Malaysia, with strong brand tracking, equity, and healthcare research capabilities. Known for breadth across consumer and healthcare categories rather than pharmaceutical market access specialisation.

Best for

Brand tracking and equity studies
Healthcare and consumer research
Cross-market ASEAN research design

Vase.ai

Est. 2016HQ: Kuala Lumpur, Malaysia

Vase.ai is a Malaysia-based research and insights technology platform offering fast, scalable online consumer surveys with strong local panel reach. Primarily a technology-enabled consumer research provider rather than a full-service pharmaceutical MR agency.

Best for

Malaysia-based research and insights platform
Fast online consumer surveys
Local panel reach across Malaysia

Rakuten Insight

Est. 2002 (as AIP)HQ: Tokyo, Japan (APAC panels incl. Malaysia)

Rakuten Insight operates large online consumer panels across the Asia-Pacific region, including Malaysia. Primarily an online panel and data collection provider for quantitative fieldwork rather than a full-service pharmaceutical research agency.

Best for

Online consumer panels across APAC
Quantitative data collection in Malaysia
Multi-country ASEAN online fieldwork

Nielsen Malaysia

Est. 1923 (Nielsen founded)HQ: Kuala Lumpur, Malaysia

Nielsen Malaysia provides consumer measurement, retail measurement, and market tracking across Malaysia. A leading market measurement firm focused on consumer and media research rather than pharmaceutical primary research.

Best for

Consumer measurement and retail data
Market measurement and tracking
Media and audience research

KOL Mapping and Payer Research in Malaysia

Malaysian KOL mapping requires tracking influence across a distributed, dual public-private, multi-language landscape. Klang Valley academic centres (University Malaya Medical Centre, Hospital Kuala Lumpur, Universiti Kebangsaan Malaysia Medical Centre) hold strong guideline and publication influence in oncology, cardiovascular, and immunology; Penang and northern hospitals (Penang General Hospital, Advanced Medical and Dental Institute) combine academic prominence with significant patient volumes; East Malaysia and regional centres (Hospital Universiti Sains Malaysia, Sarawak and Sabah tertiary hospitals) provide reach beyond Peninsular Malaysia. Effective Malaysian KOL mapping segments influence by region, institution, therapy area, and prescribing volume.

Malaysian payer research requires access to Ministry of Health procurement and formulary decision-makers, and private sector stakeholders — the most commercially important respondents in Malaysian pharmaceutical research. Payer interviews cover FUKKM listing preferences, MaHTAS evidence thresholds, public procurement criteria, cost-effectiveness benchmarks, and private-sector access dynamics. BioNixus conducts public payer and private sector interviews as dedicated payer research programs.

BioNixus conducts KOL mapping and payer research across Malaysia in oncology, cardiovascular, immunology, rare disease, metabolic, and other specialty areas. See our Malaysian pharmaceutical market research guide and top healthcare market research companies in Malaysia for details.

Methodology & Selection Criteria

This guide profiles firms with demonstrated market research operations in Malaysia as of 2026. Selection criteria: (1) active Malaysian operations with verified research capability, (2) relevance to healthcare, pharmaceutical, or consumer buyers in Malaysia, (3) established track record in Malaysian market research. Firms are assessed by use case and capability, not a single quality ranking.

This guide is maintained by the BioNixus research team. BioNixus is included and is transparent about its participation. For corrections or updates, contact our team.

Frequently Asked Questions

Who are the top market research companies in Malaysia in 2026?

Leading market research companies in Malaysia in 2026 include BioNixus, IQVIA Malaysia, Ipsos Malaysia, Kantar, Vase.ai, Rakuten Insight, and Nielsen Malaysia. BioNixus ranks first for pharmaceutical and healthcare research, with NPRA- and MaHTAS-aligned primary research, verified HCP recruitment at Malaysian academic medical centres and tertiary hospitals, and deep payer intelligence across MOH (KKM) drug procurement and the MOH Medicines Formulary (FUKKM).

What is pharmaceutical market research in Malaysia?

Pharmaceutical market research in Malaysia encompasses primary and secondary research designed to support commercial, market access, and regulatory decisions in the Malaysian healthcare system. This includes HCP attitude-and-usage surveys, KOL mapping at academic medical centres and tertiary hospitals, payer research with MOH (KKM) drug procurement and formulary decision-makers, NPRA registration and MaHTAS health technology assessment evidence-alignment studies, and health economics research. Malaysia's dual public-private system — with the Ministry of Health (KKM) operating public hospitals and a substantial private hospital sector — makes payer and access research structurally distinct, and Malaysia's role as a halal-pharmaceutical hub and ASEAN gateway adds further strategic dimensions.

How do NPRA and MaHTAS affect pharmaceutical market research in Malaysia?

The National Pharmaceutical Regulatory Agency (NPRA) is responsible for the registration and regulation of pharmaceutical products in Malaysia, while the Malaysian Health Technology Assessment Section (MaHTAS) conducts health technology assessments that inform Ministry of Health (KKM) funding and formulary decisions. For market researchers, NPRA and MaHTAS create specific research requirements: cost-effectiveness and budget impact evidence aligned to MaHTAS HTA methodology, payer perception research among MOH decision-makers and formulary committee members, evidence aligned to NPRA registration pathways, and price and access studies that account for the dual public-private funding environment.

What payer research does BioNixus conduct in Malaysia?

BioNixus conducts payer research across Malaysia, including in-depth interviews with Ministry of Health (KKM) drug procurement and pharmacy services decision-makers, MaHTAS health technology assessment stakeholders, MOH Medicines Formulary (FUKKM) committee participants, and private hospital and insurer decision-makers. Payer research is designed around the specific decision criteria applied to public procurement, FUKKM listing, and private sector access, reflecting Malaysia's dual public-private healthcare funding structure.

How much does market research cost in Malaysia?

Custom market research engagements in Malaysia typically vary by methodology, geography, respondent type, and research complexity. Pharmaceutical studies with GCP-compliant design requirements, specialist HCP recruitment at academic medical centres and tertiary hospitals, or MOH and FUKKM payer depth interviews cost more than standard consumer surveys. Studies covering both Peninsular and East Malaysia, or multi-language fieldwork across Bahasa Malaysia, English, and Chinese, add scope versus single-region, single-language designs. Programs that extend Malaysian research into the wider ASEAN region add further scope.

Is BioNixus GCP-compliant for HCP research in Malaysia?

Yes. BioNixus designs and executes Malaysian HCP research in accordance with Good Clinical Practice (GCP) principles and applicable Malaysian research ethics and data protection requirements, including the Personal Data Protection Act (PDPA). Studies involving HCPs at Malaysian academic medical centres, tertiary hospitals, and health systems are designed with appropriate ethics considerations, informed consent procedures, and data privacy protections aligned to NPRA and Ministry of Health (KKM) expectations.

Why is Malaysia strategically important as a halal-pharmaceutical and ASEAN hub?

Malaysia is a recognised global hub for halal pharmaceuticals, with established halal certification frameworks and a manufacturing base that serves both domestic demand and export markets across the Muslim-majority world. Malaysia also functions as a strategic gateway to the wider ASEAN market, with regulatory harmonisation initiatives and a central position in Southeast Asian healthcare. For pharmaceutical market researchers, this creates specific research opportunities: halal-pharma positioning and acceptance studies, ASEAN market access and launch sequencing research, and intelligence on how Malaysian NPRA and MaHTAS decisions interact with neighbouring regulatory systems.

Can Malaysian market research connect to global benchmarking?

Yes. BioNixus connects Malaysian research to global benchmarking programs using consistent instruments and methodology across markets. Malaysian HCP and payer studies can be benchmarked against other ASEAN markets, as well as US, UK, EU5, and other international cohorts — essential for global pharmaceutical clients making simultaneous market access decisions across multiple countries. Malaysia is frequently included in ASEAN and emerging-market launch sequencing, making consistent cross-market research design a practical necessity for regional and global pharma clients.

Related Resources

Top Healthcare Market Research Companies Malaysia 2026

Deep dive into the top healthcare and pharma research firms in Malaysia — NPRA and MaHTAS alignment, KOL mapping, and payer research.

Pharmaceutical Market Research Malaysia

NPRA- and MaHTAS-aligned pharmaceutical research covering HCP surveys, KOL mapping, MOH and FUKKM payer research.

Healthcare Market Research Malaysia

Malaysian healthcare research overview — HCP surveys, payer research, HEOR, and patient studies.

Healthcare Market Research

Global healthcare market research capabilities — HCP, payer, patient, and outcomes research across markets.

Plan Market Research in Malaysia

BioNixus delivers NPRA- and MaHTAS-aligned, GCP-compliant pharmaceutical and healthcare market research across Malaysia — HCP surveys at major AMCs and tertiary hospitals, KOL mapping, MOH and FUKKM payer research, and HEOR evidence generation. Global standards. In-market Malaysian execution and ASEAN reach.

Request a Proposal View Malaysian Research Capabilities